Automatic identification of small molecules that promote cell conversion and reprogramming
Type
PreprintAuthors
Napolitano, FrancescoRapakoulia, Trisevgeni

Annunziata, Patrizia
Hasegawa, Akira
Cardon, Melissa
Napolitano, Sara
Vaccaro, Lorenzo
Iuliano, Antonella
Wanderlingh, Luca Giorgio
Kasukawa, Takeya
Medina, Diego L.
Cacchiarelli, Davide
Gao, Xin

di Bernardo, Diego
Arner, Erik
KAUST Department
Computational Bioscience Research Center (CBRC)Computer Science Program
Computer, Electrical and Mathematical Sciences and Engineering (CEMSE) Division
Structural and Functional Bioinformatics Group
KAUST Grant Number
FCC/1/1976-18-01FCC/1/1976-23-01
FCC/1/1976-25-01
FCC/1/1976-26-01
Date
2020-04-02Permanent link to this record
http://hdl.handle.net/10754/662486
Metadata
Show full item recordAbstract
Abstract: Controlling cell fate has great potential for regenerative medicine, drug discovery, and basic research. Although numerous transcription factors have been discovered that are able to promote cell reprogramming and trans-differentiation, methods based on their up-regulation tend to show low efficiency. The identification of small molecules that can facilitate conversion between cell types can ameliorate this problem working through safe, rapid, and reversible mechanisms. Here we present DECCODE, an unbiased computational method for the identification of such molecules solely based on transcriptional data. DECCODE matches the largest available collection of drug-induced profiles (the LINCS database) for drug treatments against the largest publicly available dataset of primary cell transcriptional profiles (FANTOM5), to identify drugs that either alone or in combination enhance cell reprogramming and cell conversion. Extensive <jats:italic>in silico</jats:italic> and <jats:italic>in vitro</jats:italic> validation of DECCODE in the context of human induced pluripotent stem cells (hIPSCs) generation shows that the method is able to prioritize drugs enhancing cell reprogramming. We also generated predictions for cell conversion with single drugs and drug combinations for 145 different cell types and made them available for further studies.Citation
Napolitano, F., Rapakoulia, T., Annunziata, P., Hasegawa, A., Cardon, M., Napolitano, S., … Arner, E. (2020). Automatic identification of small molecules that promote cell conversion and reprogramming. doi:10.1101/2020.04.01.021089Sponsors
EA was supported by a Research Grant from MEXT to the RIKEN Center for Integrative Medical Sciences. XG was supported by funding from King Abdullah University of Science and Technology (KAUST), under award number FCC/1/1976-18-01, FCC/1/1976-23-01, FCC/1/1976-25-01, FCC/1/1976-26-01, and FCS/1/4102-02-01. DLM was supported by the Italian Telethon Foundation under the project number TMDMCBX16TT. DC was supported by Fondazione Telethon Core Grant, Armenise-Harvard Foundation Career Development Award, European Research Council (grant agreement 759154, CellKarma), and the Rita-Levi Montalcini program from MIUR.Publisher
Cold Spring Harbor LaboratoryAdditional Links
http://biorxiv.org/lookup/doi/10.1101/2020.04.01.021089https://www.biorxiv.org/content/biorxiv/early/2020/04/02/2020.04.01.021089.full.pdf
ae974a485f413a2113503eed53cd6c53
10.1101/2020.04.01.021089